Product Description: Tolterodine tartrate-d14 (Kabi-2234-d14) is deuterium labeled Tolterodine (tartrate). Tolterodine Tartrate (Kabi-2234; PNU-200583E) is a potent muscarinic receptor antagonist and shows selectivity for the urinary bladder over salivary glands in vivo.
Applications: Cancer-programmed cell death
Formula: C26H23D14NO7
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Nilvebrant L. Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists. Pharmacol Toxicol. 2002 May;90(5):260-7./[3]Andersson SH, et al. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. Drug Metab Dispos. 1998 Jun;26(6):528-35./[4]Cappon GD, et al. Tolterodine does not affect memory assessed by passive-avoidance response test in mice. Eur J Pharmacol. 2008 Jan 28;579(1-3):225-8.
CAS Number: 1191280-48-4
Molecular Weight: 489.66
Research Area: Neurological Disease;Cancer
Target: Isotope-Labeled Compounds;mAChR
Deutsch
English
